Aixin Life International, which sells nutritional and wellness products in China, raised the proposed deal size for its upcoming IPO on Tuesday. Aixin Life International is currently listed on the OTC (AIXN). The Chengdu, China-based company now plans to...read more
Aixin Life International, which sells nutritional and wellness products in China, lowered the proposed deal size for its upcoming IPO on Monday. In its latest filing, the company also disclosed financials for the three months ended March 31, 2023. Aixin Life...read more
Aixin Life International, which sells nutritional and wellness products in China, announced terms for its IPO on Wednesday. The company is currently listed on the OTC under the symbol "AIXN". The Chengdu, China-based company plans to raise $25 million by...read more
It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain ...read more
Chinese health product distributor Aixin Life International ups share offering by 36% ahead of $10 million Nasdaq uplisting
Aixin Life International, which sells nutritional and wellness products in China, raised the proposed deal size for its upcoming IPO on Tuesday. Aixin Life International is currently listed on the OTC (AIXN). The Chengdu, China-based company now plans to...read more
Chinese health product distributor Aixin Life International slashes share offering by 72% ahead of $7 million Nasdaq uplisting
Aixin Life International, which sells nutritional and wellness products in China, lowered the proposed deal size for its upcoming IPO on Monday. In its latest filing, the company also disclosed financials for the three months ended March 31, 2023. Aixin Life...read more
Chinese health product distributor Aixin Life International sets terms for $25 million Nasdaq uplisting
Aixin Life International, which sells nutritional and wellness products in China, announced terms for its IPO on Wednesday. The company is currently listed on the OTC under the symbol "AIXN". The Chengdu, China-based company plans to raise $25 million by...read more
Renaissance Capital's November IPO Market Update
It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain ...read more